Literature DB >> 18830607

Effects of antalarmin, a CRF receptor 1 antagonist, on fright reaction and endocrine stress response in crucian carp (Carassius carassius).

Stine Lastein1, Erik Höglund, Oyvind Overli, Kjell B Døving.   

Abstract

The corticotrophin-releasing factor (CRF) receptors show striking homogeneity throughout the vertebrate subphylum. In mammals, the CRF(1) receptor (CRFR(1)) plays an important role in mediating behavioral and endocrine responses to fear and stress. The specific roles of this receptor subtype in fear and stress reactions in non-mammalian vertebrates are largely unknown. Crucian carp displays the olfactory-mediated fright reaction, a stereotypic behavioral response to waterborne cues from damaged skin of conspecifics. This reaction shows several similarities to basic components of avoidance behavior in mammals. In the present study, we applied the non-peptide CRFR(1) antagonist, antalarmin, to crucian carp 1 h before exposure to conspecific skin extract. This treatment resulted in a suppression of the fright reaction. After skin extract exposure, antalarmin treatment also lead to lower plasma cortisol values, as compared to vehicle treatment. This suppression of the behavioral fright reaction and the stress induced rise in plasma cortisol in crucian carp suggests that the functions of the CRFR(1) are conserved by evolution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830607     DOI: 10.1007/s00359-008-0372-9

Source DB:  PubMed          Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol        ISSN: 0340-7594            Impact factor:   1.836


  37 in total

1.  Differential expression of corticotropin-releasing factor (CRF) and urotensin I precursor genes, and evidence of CRF gene expression regulated by cortisol in goldfish brain.

Authors:  N J Bernier; X Lin; R E Peter
Journal:  Gen Comp Endocrinol       Date:  1999-12       Impact factor: 2.822

2.  Avoidance behavior and brain monoamines in fish.

Authors:  Erik Höglund; Finn-Arne Weltzien; Joachim Schjolden; Svante Winberg; Holger Ursin; Kjell B Døving
Journal:  Brain Res       Date:  2005-01-25       Impact factor: 3.252

3.  Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity.

Authors:  Dean A Myers; Matthew Gibson; Jay Schulkin; Beverley Greenwood Van-Meerveld
Journal:  Behav Brain Res       Date:  2005-04-22       Impact factor: 3.332

4.  4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders.

Authors:  Guy Griebel; Jacques Simiand; Régis Steinberg; Mireille Jung; Danielle Gully; Pierre Roger; Michel Geslin; Bernard Scatton; Jean-Pierre Maffrand; Philippe Soubrié
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

5.  In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.

Authors:  E L Webster; D B Lewis; D J Torpy; E K Zachman; K C Rice; G P Chrousos
Journal:  Endocrinology       Date:  1996-12       Impact factor: 4.736

6.  Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.

Authors:  S R Bornstein; E L Webster; D J Torpy; S J Richman; N Mitsiades; M Igel; D B Lewis; K C Rice; H G Joost; M Tsokos; G P Chrousos
Journal:  Endocrinology       Date:  1998-04       Impact factor: 4.736

7.  The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats.

Authors:  Emily M Jutkiewicz; Susan K Wood; Hani Houshyar; Ling-Wei Hsin; Kenner C Rice; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

8.  Does amygdaloid corticotropin-releasing hormone (CRH) mediate anxiety-like behaviors? Dissociation of anxiogenic effects and CRH release.

Authors:  Z Merali; S Khan; D S Michaud; S A Shippy; H Anisman
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

9.  Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

Authors:  G Griebel; G Perrault; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1998-07       Impact factor: 4.530

10.  Effects of dopaminergic drugs on locomotor activity in teleost fish of the genus Oreochromis (Cichlidae): involvement of the telencephalon.

Authors:  E Y Mok; A D Munro
Journal:  Physiol Behav       Date:  1998-06-01
View more
  4 in total

1.  Crowding stress inhibits serotonin 1A receptor-mediated increases in corticotropin-releasing factor mRNA expression and adrenocorticotropin hormone secretion in the Gulf toadfish.

Authors:  Lea R Medeiros; Maria C Cartolano; M Danielle McDonald
Journal:  J Comp Physiol B       Date:  2013-12-21       Impact factor: 2.200

2.  Regulation of feeding behavior and psychomotor activity by corticotropin-releasing hormone (CRH) in fish.

Authors:  Kouhei Matsuda
Journal:  Front Neurosci       Date:  2013-05-30       Impact factor: 4.677

3.  Central corticotropin releasing factor and social stress.

Authors:  Tobias Backström; Svante Winberg
Journal:  Front Neurosci       Date:  2013-07-09       Impact factor: 4.677

4.  Learning and CRF-Induced Indecision during Escape and Submission in Rainbow Trout during Socially Aggressive Interactions in the Stress-Alternatives Model.

Authors:  Tangi R Summers; Torrie L Summers; Russ E Carpenter; Justin P Smith; Samuel L Young; Brandon Meyerink; T Zachary Orr; David H Arendt; Cliff H Summers
Journal:  Front Neurosci       Date:  2017-09-15       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.